Amwell (NYSE: AMWL) reported Q2 EPS of ($3.36), $3.16 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $62.8 million versus the consensus estimate of $61.62 million.

For earnings history and earnings-related data on Amwell (AMWL) click here.